Encompass More Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
CGH
CNB
AP
COPPSERS
OIAM
Encompass More Asset Management's GILD Position: Q2 2026 in Review
Encompass More Asset Management increased its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, buying an estimated $6.85K and bringing the position to 2,935 shares worth $371K. The position accounts for 0.05% of the portfolio, ranked #198.
Encompass More Asset Management first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $660K in Q1 2025. 341 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Encompass More Asset Management held 2,935 shares of Gilead Sciences worth $371K as of Q2 2026.
- Encompass More Asset Management bought 52 Gilead Sciences shares in Q2 2026, an estimated $6.85K.
- Gilead Sciences made up 0.05% of Encompass More Asset Management's portfolio in Q2 2026, its #198 holding.
- Encompass More Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
- Encompass More Asset Management's Gilead Sciences position peaked at $660K in Q1 2025.
- 341 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.